151 related articles for article (PubMed ID: 6130101)
1. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
[TBL] [Abstract][Full Text] [Related]
2. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
Shibasaki T; Masui H
J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
5. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
[TBL] [Abstract][Full Text] [Related]
6. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
[TBL] [Abstract][Full Text] [Related]
7. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
Suda T; Tomori N; Tozawa F; Demura H; Shizume K
J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
[TBL] [Abstract][Full Text] [Related]
8. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
[TBL] [Abstract][Full Text] [Related]
9. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
12. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
[TBL] [Abstract][Full Text] [Related]
13. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
Chan JS; Lu CL; Seidah NG; Chretien M
Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
[TBL] [Abstract][Full Text] [Related]
15. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
16. Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome.
Bertagna X; Luton JP; Binoux M; Bricaire H; Girard F
J Clin Endocrinol Metab; 1979 Oct; 49(4):527-32. PubMed ID: 225344
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
18. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.
Westphal M; Jaquet P; Wilson CB
Acta Neuropathol; 1986; 71(1-2):111-8. PubMed ID: 3022531
[TBL] [Abstract][Full Text] [Related]
19. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
[TBL] [Abstract][Full Text] [Related]
20. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome.
Lüdecke DK; Westphal M; Schabet M; Höllt V
Horm Res; 1980; 13(4-5):259-79. PubMed ID: 6268513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
